Bio-Path Holdings shares are trading higher Friday after the company announced interim results from its Phase 2 study of prexigebersen in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia.
Bitcoin (CRYPTO: BTC) is predicted to reach $1 million by 2033 and hit a cycle-high of $200,000 by 2025, according to a new research report by Bernstein</